The Schall Law Firm Invites Shareholders with Losses to Join a Securities Class Action Lawsuit

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against TELUS International Date: February 8, 2025 LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TELUS International (Cda) Inc. (“Telus” or “the Company”) (NYSE:TIXT)…

Read More

“Join the Fight: Shareholders Urged to Take Action Against Walgreens Boots Alliance Inc. (WBA) with The Gross Law Firm”

The Gross Law Firm Notice to Walgreens Boots Alliance Shareholders Overview New York, Feb. 06, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). This notice may have significant implications for investors and the company’s future. Implications for Shareholders Shareholders of Walgreens Boots…

Read More

Breaking News: Eagle Pharmaceuticals Wins Top Prize for Poster at International Society for Anaesthetic Pharmacology’s 32nd Annual Meeting!

Unpacking the Intriguing World of Pharmacokinetics and Pharmacodynamics An Inside Look at the Research and Development Process Have you ever wondered what goes on behind the scenes in the world of pharmaceuticals? Well, today we are diving headfirst into the fascinating realm of pharmacokinetics and pharmacodynamics. A recent study has shed light on the interim…

Read More

Rosen, a Leading Investor Rights Law Firm, Encourages Regeneron Pharmaceuticals, Inc.

Rosen Law Firm Reminds Regeneron Pharmaceuticals Investors of Lead Plaintiff Deadline January 23, 2025 NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the…

Read More